Avenue Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • ATXI
Stock Symbol
  • Share Price
  • $1.79
  • (As of Friday Closing)

Avenue Therapeutics General Information

Description

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 2 Gansevoort Street
  • 9th Floor
  • New York, NY 10014
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avenue Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.79 $1.83 $1.75 - $12.34 $30M 16.7M 315K -$0.29

Avenue Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 98,529 95,324 146,208 52,802
Revenue 0 0 0 0
EBITDA (4,940) (5,213) (26,265) (21,641)
Net Income (4,907) (5,151) (25,908) (21,548)
Total Assets 1,944 3,245 8,915 4,525
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avenue Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avenue Therapeutics‘s full profile, request access.

Request a free trial

Avenue Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the
Drug Discovery
New York, NY
4 As of 2020
000.00
0000 0000-00-00
000000&0 000.00

000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000 000000000
Wilmington, DE
0000 As of 0000
00000000000

000000

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000000000000
Seattle, WA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avenue Therapeutics Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Incyte Corporate Backed or Acquired Wilmington, DE 0000 00000000000
000000 Formerly VC-backed Seattle, WA 000 00000 00000000 00000
0000000 Formerly VC-backed Chesterbrook, PA 00 00000 000000000 00000
00000 000000000000 Corporation South San Francisco, CA 00 00000 000000000 00000
00000 Corporate Backed or Acquired Campbell, CA 00 00000 000000&0
You’re viewing 5 of 15 competitors. Get the full list »

Avenue Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Lucy Lu MD Chief Executive Officer & Board Member
Joseph Vazzano Chief Financial Officer, Finance
Lindsay Rosenwald MD Executive Chairman & Board Member
Scott Reines Ph.D Chief Medical Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Avenue Therapeutics Board Members (6)

Name Representing Role Since
0000000 00000 00 Avenue Therapeutics Board Member 000 0000
0000000 000000000 00 Avenue Therapeutics Executive Chairman & Board Member 000 0000
0000 00 00 Avenue Therapeutics Chief Executive Officer & Board Member 000 0000
0000 0000000000 Avenue Therapeutics Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Avenue Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avenue Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avenue Therapeutics‘s full profile, request access.

Request a free trial